iMDx Inc.
@imdxinc.com
Transforming Diagnostics. Empowering Care. Precision diagnostics in oncology and transplantation—delivered with purpose, powered by science. EXPLORE OUR PRODUCTS ABOUT iMDx Science with Purpose At iMDx, we advance precision medicine through innovative diagnostics that serve the needs of researchers, clinicians, and healthcare systems. Whether enabling early detection, guiding treatment, or accelerating discovery, our solutions are designed […]
iMDx Inc.'s Company Logos
iMDx Inc.'s Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#242177
Lucky Point
36, 33, 119
242, 57, 30
70, 72, 0, 53
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#17A5DE
Curious Blue
23, 165, 222
197, 81, 48
90, 26, 0, 13
About iMDx Inc.
iMDx, formerly known as Oncocyte, is revolutionizing precision medicine through cutting-edge diagnostics tailored for oncology and transplantation. The company is dedicated to empowering healthcare professionals with innovative tools designed to enhance diagnosis and treatment across various medical spectrums.
iMDx offers an array of clinical products, including the GraftAssureCore™, a blood-based test for post-transplant monitoring, and the GraftAssureIQ™, a research assay that helps quantify donor-derived cell-free DNA (dd-cfDNA). Both products facilitate critical decision-making for transplant recipients and their care teams. In addition, iMDx is actively developing other diagnostic solutions, such as DetermaCNI and DetermaIO, which aim to improve outcomes in cancer care.
Guided by a patient-first philosophy and a commitment to scientific integrity and innovation, iMDx is paving the way for more accessible, transformative diagnostics that ultimately enhance patient care and support groundbreaking research in the medical field.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Related Brands
Tags
Molecular diagnostic tests
Dd-cfDNA assays
Digital PCR diagnostics
Transplant monitoring
Oncology immunotherapy diagnostics
